Annovis Bio, Inc.ANVSNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-1405.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-23869.65%
Q3 202531.69%
Q2 202536.96%
Q1 20252.25%
Q4 2024-158.81%
Q3 20245.15%
Q2 202452.01%
Q1 202424.90%
Q4 20230.05%
Q3 20232.46%
Q2 202317.37%
Q1 2023-222.11%
Q4 20229.47%
Q3 202240.44%
Q2 2022-121.54%
Q1 2022-70.79%
Q4 2021-1.49%
Q3 202144.56%
Q2 2021-27.06%
Q1 2021-223.11%
Q4 202016.98%
Q3 202029.66%
Q2 2020-35.18%
Q1 2020-1747.41%
Q4 2019-17.56%
Q3 201970.33%
Q2 201934.16%
Q1 2019-200.34%
Q4 201840.87%
Q3 201834.51%
Q2 2018-25.32%
Q1 20180.00%